John Mendlein, Director: Fate Therapeutics FATE Buy · Filed 23/01/13

Trade details

Type: Insider buy
Amount: $198,906.33
Shares · price: 36,631 sh · $5.43 a share
Held after: 282,770 sh
Stock: Fate Therapeutics FATE
Person: John MendleinDirector
Trade date: 23/01/13
Filed: 23/01/13
Days to filing: 0 days

Holdings up 14.9%

Insiders buying this week: 1 insiders
Holding change: +14.9%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/14~23/02/12

John Mendlein's recent trades

John MendleinDirector
Planned saleFate Therapeutics
Planned sale
Fate Therapeutics
FATE
$38.9K
38,428 sh
$38.9K
Filed 25/12/29
Traded 25/12/24
John MendleinDirector
BuyFate Therapeutics
Buy
Fate Therapeutics
FATE
$499.2K
88,048 sh
$499.2K
Filed 23/01/13
Traded 23/01/11

John Mendlein, Director — bought $198.9K of Fate Therapeutics FATE · 36,631 sh @ $5.43 | Whalegun